Ralph Niven

Insider Reports History

Entity
Individual
Location
C/O Aerovate Therapeutics, Inc., 200 Berkeley Street, Floor 18, Boston, MA
Signature
/s/ George A. Eldridge, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ralph Niven:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aerovate Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Stock Option (Right to Buy) 41.7K $563K $13.49 Feb 5, 2024 Direct
Aerovate Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Common Stock 1.61K $28.1K $17.45 Feb 5, 2024 Direct

Insider Reports Filed by Ralph Niven

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVTE Aerovate Therapeutics, Inc. Feb 5, 2024 8 -$71K 4 Feb 7, 2024 CHIEF SCIENTIFIC OFFICER
AVTE Aerovate Therapeutics, Inc. Jan 22, 2024 1 $0 4 Jan 24, 2024 CHIEF SCIENTIFIC OFFICER
AVTE Aerovate Therapeutics, Inc. Jan 5, 2024 9 -$78.8K 4 Jan 8, 2024 CHIEF SCIENTIFIC OFFICER
AVTE Aerovate Therapeutics, Inc. Dec 5, 2023 8 -$65.7K 4 Dec 7, 2023 CHIEF SCIENTIFIC OFFICER
AVTE Aerovate Therapeutics, Inc. Nov 22, 2023 8 -$179K 4 Nov 27, 2023 CHIEF SCIENTIFIC OFFICER
AVTE Aerovate Therapeutics, Inc. Jul 5, 2023 9 -$34.4K 4 Jul 7, 2023 CHIEF SCIENTIFIC OFFICER
AVTE Aerovate Therapeutics, Inc. Jun 5, 2023 8 -$32K 4 Jun 7, 2023 CHIEF SCIENTIFIC OFFICER
AVTE Aerovate Therapeutics, Inc. May 5, 2023 9 -$42.4K 4 May 9, 2023 CHIEF SCIENTIFIC OFFICER
AVTE Aerovate Therapeutics, Inc. Apr 5, 2023 9 -$36.4K 4 Apr 7, 2023 CHIEF SCIENTIFIC OFFICER
AVTE Aerovate Therapeutics, Inc. Mar 6, 2023 9 -$48.9K 4 Mar 8, 2023 CHIEF SCIENTIFIC OFFICER
AVTE Aerovate Therapeutics, Inc. Feb 6, 2023 9 -$50.1K 4 Feb 8, 2023 CHIEF SCIENTIFIC OFFICER
AVTE Aerovate Therapeutics, Inc. Jan 5, 2023 8 -$54.8K 4 Jan 9, 2023 CHIEF SCIENTIFIC OFFICER
AVTE Aerovate Therapeutics, Inc. Dec 5, 2022 8 -$34.6K 4 Dec 7, 2022 CHIEF SCIENTIFIC OFFICER
AVTE Aerovate Therapeutics, Inc. Nov 7, 2022 11 -$38.6K 4 Nov 9, 2022 CHIEF SCIENTIFIC OFFICER
AVTE Aerovate Therapeutics, Inc. Oct 5, 2022 9 -$30.9K 4 Oct 7, 2022 CHIEF SCIENTIFIC OFFICER
AVTE Aerovate Therapeutics, Inc. Sep 6, 2022 8 -$38.2K 4 Sep 7, 2022 Chief Scientific Officer
AVTE Aerovate Therapeutics, Inc. Aug 18, 2022 8 -$43.1K 4 Aug 19, 2022 Chief Scientific Officer
AVTE Aerovate Therapeutics, Inc. Dec 14, 2021 1 $0 4 Dec 16, 2021 Chief Development Officer
AVTE Aerovate Therapeutics, Inc. Jun 29, 2021 0 $0 3 Jun 29, 2021 Chief Development Officer
AVTE Aerovate Therapeutics, Inc. Apr 2, 2021 3 $0 4 Jul 1, 2021 Chief Development Officer